“…Our previous studies demonstrated that human serum can solubilize a measurable amount of additional cholesterol and this amount was designated serum cholesterol binding reserve (SCBR). SCBR was found to be decreased in patients with premature myocardial infarction (Hsia, Chao, Hennekens and Reader 1975;Hsia, Briese and Hoffman 1976), patients with diabetes mellitus (Hsia, Fishman, Briese, Christakis, Burr and Bricker 1978), and patients with the nephrotic syndrome (Perez, Levine, Gomez and Hsia 1979). Since the last two groups of patients have a high incidence of atherosclerotic complications, it is suggested that decreased SCBR may be a risk factor for the development of premature atherosclerosis.…”